Skip to main content
VREXVarex Imaging CorporationSell5.7·$10.61-0.66%
Open full analysis

Varex Imaging Corporation (VREX) Stock Analysis

Recovery setup · Catalyst-Driven edge

SellVALUE-TRAP 1/5Moderate Confidence

Healthcare · Medical Devices

Sell if holding. Engine safety override at $10.61: Quality below floor (3.3 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 5.7/10 and A.R:R 4.5:1 is above the 1.5:1 BUY gate. Specifically: Below-average business quality; Below long-term trend.

Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. It operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and... Read more

$10.61+47.6% A.UpsideScore 5.7/10#20 of 64 Medical Devices
QualityF-score8 / 9FCF yield-9.01%
Stop $9.87Target $15.66(analyst − 13%)A.R:R 4.5:1
Analyst target$18.00+69.7%5 analysts
$15.66our TP
$10.61price
$18.00mean
$22

Sell if holding. Engine safety override at $10.61: Quality below floor (3.3 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 5.7/10 and A.R:R 4.5:1 is above the 1.5:1 BUY gate. Specifically: Below-average business quality; Below long-term trend. Chart setup: Death cross but MACD improving, RSI 43. Score 5.7/10, moderate confidence.

Passes 8/10 gates (positive momentum, favorable risk/reward ratio, clean insider activity, no SEC red flags, news events none recent, earnings proximity 26d clear, semi cycle peak clear, materials cycle peak clear). Fails on death cross (50MA < 200MA). Suitability: aggressive.

TrendMatrix Research · upcoming catalyst calendar

Upcoming dated catalysts

Thu, Jul 30, 202626d to earnings· next earnings call

Thesis

Rewards
No bull case signals
Risks
Quality below floor (3.3 < 4.0)

Key Metrics

P/E (TTM)
P/E (Fwd)10.0
Mkt Cap$447M
EV/EBITDA8.4
Profit Mgn-9.6%
ROE-15.7%
Rev Growth1.5%
Beta0.90
DividendNone
Rating analysts11

Quality Signals

Piotroski F8/9

Options Flow

IV118%elevated

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

Rating Breakdown

2 floor-breakers·1 ceiling hit

Unprofitable operations — net margin -9.6%. Quality floor flags this regardless of sector context.static

Roe
0.0
Net Margin
0.0
Fcf Quality
0.0
Roa
2.1
Gross Margin
2.7
Operating Margin
2.7
Moat
3.9
Piotroski F
8.9
Current Ratio
9.8
Cash-burning: FCF -5% of revenueNo competitive moatStrong Piotroski F-Score: 8/9

Ranks in the bottom of its industry peers on the composite signal. Better names in the same sector exist.static

Growth Rank
1.6
Quality Rank
3.1
Value Rank
9.4
GatesDeath cross (50MA < 200MA)Momentum 4.6<5.5 (soft — BUY_NOW allowed but watch)Momentum 4.6>=4.5A.R:R 4.5 ≥ 1.5Insider activity: OKNo SEC red flagsNEWS EVENTS NONE RECENTEARNINGS PROXIMITY 26d clearSEMI CYCLE PEAK CLEARMATERIALS CYCLE PEAK CLEARRecoverySuitability: Aggressive
RSI
43 · Neutral
20D MA 50D MA 200D MADEATH CROSSSupport $9.59Resistance $11.65

Price Targets

$10
$16
A.Upside+47.6%
A.R:R4.5:1

Position Sizing

ConvictionNone
Suggested %0.5%
Max %1%
RegimeSteady

Risk Alerts

! Quality below floor (3.3 < 4.0)
! Death cross — 50-day MA below 200-day MA

Earnings

B
B
B
M
3/4 beats
Next Earnings2026-07-30 (26d)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is VREX stock a buy right now?

Sell if holding. Engine safety override at $10.61: Quality below floor (3.3 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 5.7/10 and A.R:R 4.5:1 is above the 1.5:1 BUY gate. Specifically: Below-average business quality; Below long-term trend. Chart setup: Death cross but MACD improving, RSI 43. Prior stop was $9.87. Score 5.7/10, moderate confidence.

What is the VREX stock price target?

Take-profit target: $15.66 (+47.6% upside). Prior stop was $9.87. Stop-loss: $9.87.

What are the risks of investing in VREX?

Quality below floor (3.3 < 4.0).

Is VREX overvalued or undervalued?

Varex Imaging Corporation trades at a P/E of N/A (forward 10.0). TrendMatrix value score: 9.0/10. Verdict: Sell.

What do analysts say about VREX?

11 analysts cover VREX with a consensus score of 4.2/5. Average price target: $18.

What does Varex Imaging Corporation do?Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. It operates through two segments,...

Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. It operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers. This segment's products are used in a range of applications, including CT, mammography, oncology, cardiac, surgery, dental, and other diagnostic radiography uses. The Industrial segment designs, develops, manufactures, sells, and services Linatron X-ray linear accelerators, non-intrusive cargo inspection systems, X-ray tubes, digital detectors, high voltage connectors, and coolers for use in security and inspection applications, such as baggage screening at airports, cargo screening at ports and borders, and nondestructive testing, irradiation, and inspection in various applications. It sells its products through imaging system original equipment manufacturers, independent service companies, and distributors, as well as directly to end-users. The company has operations in North America, Latin America, Europe, the Middle East, India, Africa, Asia, and Australia. The company was incorporated in 2016 and is headquartered in Salt Lake City, Utah.

Related stocks: DCTH (Delcath Systems, Inc.) · BWAY (Brainsway Ltd.) · TCMD (Tactile Systems Technology, Inc) · ATEC (Alphatec Holdings, Inc.) · MOBI (Mobia Medical, Inc.)
Home Stocks VREX

Latest news

No recent news